President Donald Trump’s approval rating is no longer nearing historic lows, after rising slightly in the latest Reuters/Ipsos poll.
“Globally, generics is consolidating,” chief executive Rajeev Nannapaneni told Mint, pointing out that most Western companies have exited the commodity generics space, leaving Indian drugmakers to ...